Cargando…
APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects
Genetic factors can determine the high variability observed in response to lipid-lowering therapy with statins. Nonetheless, the frequency of single nucleotide polymorphisms (SNPs) and their impact can vary due to ethnicity. Because the Chilean population carries a strong Amerindian background, the...
Autores principales: | Lagos, Jenny, Zambrano, Tomás, Rosales, Alexy, Salazar, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425056/ https://www.ncbi.nlm.nih.gov/pubmed/25860945 http://dx.doi.org/10.3390/ijms16047890 |
Ejemplares similares
-
SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals
por: Prado, Yalena, et al.
Publicado: (2015) -
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
por: Ubilla, Carmen Gloria, et al.
Publicado: (2021) -
Association between APOE polymorphisms and lipid profile in Mexican Amerindian population
por: Martínez‐Magaña, José J., et al.
Publicado: (2019) -
CYP2C19(⁎)2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls
por: Ruedlinger, Jenny, et al.
Publicado: (2017) -
Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study
por: Paez, Isis, et al.
Publicado: (2023)